Anti-EGFL7 antibodies enhance stress-induced endothelial cell death and anti-VEGF efficacy

Genetically Engineered Mouse Models: Closing the Gap between Preclinical Data and Trial Outcomes

(2012) M. Singh et al.   CANCER RESEARCH

Anti-VEGF antibody therapy does not promote metastasis in genetically engineered mouse tumour models

(2012) Mallika Singh et al.   JOURNAL OF PATHOLOGY

A murine lung cancer co-clinical trial identifies genetic modifiers of therapeutic response

(2012) Zhao Chen et al.   NATURE

Antiangiogenic therapy—evolving view based on clinical trial results

(2012) Gordon C. Jayson et al.   Nature Reviews Clinical Oncology

Incorporation of Bevacizumab in the Primary Treatment of Ovarian Cancer

(2011) Robert A. Burger et al.   NEW ENGLAND JOURNAL OF MEDICINE

Impaired angiogenesis and altered Notch signaling in mice overexpressing endothelial Egfl7

(2010) D. Nichol et al.   BLOOD

Expression and clinical significance of EGFL7 in malignant glioma

(2010) Chun-hai Huang et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Assessing therapeutic responses in Kras mutant cancers using genetically engineered mouse models

(2010) Mallika Singh et al.   NATURE BIOTECHNOLOGY

Quantifying Antivascular Effects of Monoclonal Antibodies to Vascular Endothelial Growth Factor: Insights from Imaging

(2009) J. P.B. O'Connor et al.   CLINICAL CANCER RESEARCH

Goldie–Coldman and bevacizumab beyond disease progression

(2009) Bruce J. Giantonio   Nature Reviews Clinical Oncology

The Clinical Benefit of Bevacizumab in Metastatic Colorectal Cancer Is Independent of K-ras Mutation Status: Analysis of a Phase III Study of Bevacizumab with Chemotherapy in Previously Untreated Metastatic Colorectal Cancer

(2009) H. I. Hurwitz et al.   ONCOLOGIST

Maximum tolerated dose: clinical endpoint for a bygone era?

(2009) Chris H. Takimoto   Targeted Oncology

Bevacizumab Beyond First Progression Is Associated With Prolonged Overall Survival in Metastatic Colorectal Cancer: Results From a Large Observational Cohort Study (BRiTE)

(2008) Axel Grothey et al.   JOURNAL OF CLINICAL ONCOLOGY

Role of Bv8 in neutrophil-dependent angiogenesis in a transgenic model of cancer progression

(2008) F. Shojaei et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Epidermal growth factor-like domain 7 protects endothelial cells from hyperoxia-induced cell death

(2007) Dong Xu et al.   AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY